Annastasiah M.

Annastasiah M. is the President and COO of Red Abbey Labs since October 2020, where expertise in neuroscience and neurotechnology drives innovations for brain diseases. In addition, Annastasiah serves in board and advisory roles for the Academic Drug Discovery Consortium and BelCham, contributing to collaborative efforts in drug discovery and international business growth. As the founder of Mawambo, Annastasiah promotes breakthroughs in life sciences and digital health by integrating emerging technologies. An Adjunct Assistant Professor of Medicine at Nova Southeastern University, Annastasiah has a rich background in healthcare and business, including founding the Alliance for Artificial Intelligence in Healthcare and working in strategic roles at ICON Government and Public Health Solutions, Johns Hopkins Medicine, and Booz & Company. Annastasiah holds a PhD in Cellular and Molecular Medicine from The Johns Hopkins University School of Medicine, a Certificate in Artificial Intelligence from MIT Sloan, and a BS in Chemistry from the University of Pittsburgh.